Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Laidlaw

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2022
Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir TreatmentBrian P Epling, Joseph M Rocco, Kristin L Boswell, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2022
COVID-19 redux: clinical, virologic, and immunologic evaluation of clinical rebound after nirmatrelvir/ritonavirBrian P Epling, Joseph M Rocco, Kristin L Boswell, et al.
Frontiers in Immunology|December 23, 2021
Rapid Emergence of T Follicular Helper and Germinal Center B Cells Following Antiretroviral Therapy in Advanced HIV DiseaseChun-Shu Wong, Clarisa M Buckner, Silvia Lucena Lage, et al.
Journal of Virology|September 12, 2024
SARS-CoV-2 infection perturbs the gastrointestinal tract and induces modest microbial translocation across the intestinal barrierKelsie Brooks, Christine E Nelson, Cynthia Aguilar, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2022
Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir TreatmentBrian P Epling, Joseph M Rocco, Kristin L Boswell, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2022
COVID-19 redux: clinical, virologic, and immunologic evaluation of clinical rebound after nirmatrelvir/ritonavirBrian P Epling, Joseph M Rocco, Kristin L Boswell, et al.
Frontiers in Immunology|December 23, 2021
Rapid Emergence of T Follicular Helper and Germinal Center B Cells Following Antiretroviral Therapy in Advanced HIV DiseaseChun-Shu Wong, Clarisa M Buckner, Silvia Lucena Lage, et al.
Journal of Virology|September 12, 2024
SARS-CoV-2 infection perturbs the gastrointestinal tract and induces modest microbial translocation across the intestinal barrierKelsie Brooks, Christine E Nelson, Cynthia Aguilar, et al.
Pageof 4